Zydus Lifesciences Chlorpromazine Hydrochloride 25 mg 100-count Tablets Recalled Nationwide (2025)
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride tablets, 25 mg, 100-count bottles distributed nationwide by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. Stop using the product and contact your healthcare provider or Zydus Pharmaceuticals (USA) Inc. for
About This Product
Chlorpromazine hydrochloride is an antipsychotic medication used to treat certain psychiatric conditions. It is prescribed by healthcare providers and distributed nationally in the United States.
Why This Is Dangerous
The recall is due to CGMP deviations and the presence of an impurity above acceptable intake limits, which could pose health risks with exposure.
Industry Context
This recall is not described as part of a broader industry pattern in the provided notice.
Real-World Impact
For patients currently using this medication, stopping therapy should be done under clinician guidance to avoid withdrawal or symptom recurrence.
Practical Guidance
How to identify if yours is affected
- Check the bottle label for NDC 70710-1130-1
- Confirm 100-count bottle size and Rx-only status
- Verify the distribution country as the USA
- Refer to the FDA recall page for the official recall number D-0632-2025
Where to find product info
FDA recall enforcement page for D-0632-2025 and the manufacturer communications
What timeline to expect
Refunds or replacements typically 4-6 weeks after submission
If the manufacturer is unresponsive
- Escalate with your pharmacist or clinician
- Submit complaints to FDA recall page if the company is unresponsive
- Keep copies of all correspondence and receipts
How to prevent similar issues
- Verify NDCs before dispensing any prescription drug
- Ask for manufacturer recall notices when starting therapy
- Consult your clinician before stopping medications without guidance
Documentation advice
Keep bottle, packaging, receipts, and any recall notices; document dates, conversations, and actions taken
Product Details
NDC: 70710-1130-1; 25 mg tablets; 100-count bottles; Rx only; Manufactured by Zydus Lifesciences Ltd., Baddi, India; Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; Nationwide distribution in the USA; Recall date: 2025-09-03; Status: ACTIVE; Reason: CGMP Deviations: N-Nitroso Desmethyl Chlorpromazine above acceptable intake; Model numbers not specified.
Reported Incidents
No injuries or incidents have been reported.